Retour
47
49
Fourchette du Jour
62,69 €
63,62 €
Fourchette 52 Semaines
47,50 €
82,22 €
Volume
856 291
Moyenne 50J / 200J
71,41 €
/
66,89 €
Clôture Précédente
62,04 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 23,6 | 0,2 |
| P/B | 152,9 | 3,0 |
| ROE % | 153,6 | 3,6 |
| Net Margin % | 22,7 | 3,8 |
| Rev Growth 5Y % | 33,2 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
76,14 €
+20.4%
Low: 56,00 €
High: 94,00 €
P/E Prévisionnel
7,89
BPA Prévisionnel
8,02 €
Croissance BPA (est.)
+0,0%
CA Est.
1,76B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
8,61 €
8,41 € – 8,77 €
|
1,78B | 1 |
| FY2029 |
9,53 €
9,32 € – 9,71 €
|
1,92B | 1 |
| FY2028 |
10,94 €
10,71 € – 11,17 €
|
2,14B | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-17 | 2,20 € | -0,24 € | -110,9% |
| 2025-11-03 | 1,63 € | 1,72 € | +5,5% |
| 2025-08-05 | 1,23 € | 1,54 € | +25,2% |
| 2025-05-06 | 0,95 € | 1,11 € | +16,8% |
| 2025-02-18 | 1,17 € | 1,26 € | +7,7% |
| 2024-10-31 | 0,98 € | 1,27 € | +29,6% |
| 2024-08-06 | 0,76 € | 0,91 € | +19,7% |
| 2024-05-07 | 0,70 € | 0,79 € | +12,9% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 33,23% annually over 5 years — strong growth
Earnings declined -28,64% over the past year
ROE of 153,59% indicates high profitability
Net margin of 22,69% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 644,59M in free cash flow
Croissance
Revenue Growth (5Y)
33,23%
Revenue (1Y)37,55%
Earnings (1Y)-28,64%
FCF Growth (3Y)31,41%
Qualité
Return on Equity
153,59%
ROIC1254,19%
Net Margin22,69%
Op. Margin58,45%
Sécurité
Debt / Equity
0,00
Current Ratio4,66
Interest Coverage45,03
Valorisation
P/E Ratio
23,55
Forward P/E7,89
P/B Ratio152,89
EV/EBITDA8,98
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 37,55% | Revenue Growth (3Y) | 29,78% |
| Earnings Growth (1Y) | -28,64% | Earnings Growth (3Y) | 6,08% |
| Revenue Growth (5Y) | 33,23% | Earnings Growth (5Y) | -5,82% |
| Profitability | |||
| Revenue (TTM) | 1,40B | Net Income (TTM) | 316,89M |
| ROE | 153,59% | ROA | 12,55% |
| Gross Margin | 78,13% | Operating Margin | 58,45% |
| Net Margin | 22,69% | Free Cash Flow (TTM) | 644,59M |
| ROIC | 1254,19% | FCF Growth (3Y) | 31,41% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 4,66 |
| Interest Coverage | 45,03 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 23,55 | Forward P/E | 7,89 |
| P/B Ratio | 152,89 | P/S Ratio | 5,34 |
| PEG Ratio | -1,04 | Forward PEG | N/A |
| EV/EBITDA | 8,98 | Fwd EV/EBITDA | 5,54 |
| Forward P/S | 4,25 | Fwd Earnings Yield | 12,67% |
| FCF Yield | 8,64% | ||
| Market Cap | 7,46B | Enterprise Value | 7,33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,40B | 1,02B | 829,25M | 660,12M | 443,31M |
| Net Income | 316,89M | 444,09M | 281,59M | 202,13M | 402,71M |
| EPS (Diluted) | 2,56 | 3,43 | 2,10 | 1,44 | 2,74 |
| Gross Profit | 1,09B | 855,91M | 636,89M | 520,81M | 361,90M |
| Operating Income | 816,29M | 551,48M | 337,57M | 267,53M | 275,90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,53B | 2,06B | 1,73B | 1,84B | 1,10B |
| Total Liabilities | 2,48B | 1,70B | 1,65B | 1,67B | 907,48M |
| Shareholders' Equity | 48,81M | 363,82M | 83,81M | 169,80M | 196,95M |
| Total Debt | 0,0 | 1,51B | 1,50B | 1,51B | 876,67M |
| Cash & Equivalents | 133,82M | 115,85M | 118,37M | 234,20M | 118,72M |
| Current Assets | 825,21M | 1,09B | 746,42M | 739,01M | 926,29M |
| Current Liabilities | 177,09M | 139,10M | 112,49M | 130,79M | 117,15M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#466 of 1049
Custom
Capital Light Compounder
#69 of 220
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Capital Light Compounder
Mar 24, 2026